Abstract
Coronary artery disease (CAD) is the main cause of death and remains a major health problem worldwide. Myocardial perfu-sion imaging is a well established noninvasive method for assessing CAD. This review summarizes the development of various ra-diotracers for myocardial perfusion imaging, including single photon emission computed tomography (SPECT) perfusion imaging agents and positron emission tomography (PET) perfusion imaging agents and introduces novel basic research data related to this area. In addi-tion, the current state of the art in myocardial perfusion imaging agents and the future direction are discussed in this review.
Keywords: Radiotracers, myocardial, perfusion, imaging, nuclear medicine, Coronary artery disease (CAD), single photon emission computed tomography (SPECT), positron emission tomography (PET), infarction
Current Pharmaceutical Design
Title: Development of Radiolabeled Compounds for Myocardial Perfusion Imaging
Volume: 18 Issue: 8
Author(s): Xiao Lin, Junbo Zhang, Xuebin Wang, Zhigang Tang, Xianzhong Zhang and Jie Lu
Affiliation:
Keywords: Radiotracers, myocardial, perfusion, imaging, nuclear medicine, Coronary artery disease (CAD), single photon emission computed tomography (SPECT), positron emission tomography (PET), infarction
Abstract: Coronary artery disease (CAD) is the main cause of death and remains a major health problem worldwide. Myocardial perfu-sion imaging is a well established noninvasive method for assessing CAD. This review summarizes the development of various ra-diotracers for myocardial perfusion imaging, including single photon emission computed tomography (SPECT) perfusion imaging agents and positron emission tomography (PET) perfusion imaging agents and introduces novel basic research data related to this area. In addi-tion, the current state of the art in myocardial perfusion imaging agents and the future direction are discussed in this review.
Export Options
About this article
Cite this article as:
Lin Xiao, Zhang Junbo, Wang Xuebin, Tang Zhigang, Zhang Xianzhong and Lu Jie, Development of Radiolabeled Compounds for Myocardial Perfusion Imaging, Current Pharmaceutical Design 2012; 18 (8) . https://dx.doi.org/10.2174/138161212799315876
DOI https://dx.doi.org/10.2174/138161212799315876 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Usefulness of Magnetic Resonance Imaging in Cardiac and Enovascular Intervention
Current Medical Imaging Subject Index To Volume 6
Cardiovascular & Hematological Disorders-Drug Targets Increased Neutrophil-to-lymphocyte Ratios are Associated with Greater Risk of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Current Neurovascular Research Curcumin, Hesperidin, and Rutin Selectively Interfere with Apoptosis Signaling and Attenuate Streptozotocin-Induced Oxidative Stress- Mediated Hyperglycemia
Current Neurovascular Research Ca2+ Signalling in Damaged Endothelium: Do Connexin Hemichannels Aid in Filling the Gap?
Current Drug Therapy New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention
Current Drug Targets Cardiac Tumors: Clinical Perspective and Therapeutic Considerations
Current Drug Targets Ginger and Heart Health: From Mechanisms to Therapeutics
Current Molecular Pharmacology Vasopressin and Terlipressin in Neonates and Children with Refractory Septic Shock
Current Drug Metabolism Chemistry and Pharmacology of Bioactive Molecule -Coenzyme Q10: A Brief Note
Current Bioactive Compounds Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry Clinical Studies with Sirolimus, Zotarolimus, Everolimus and Biolimus A9 Drug- Eluting Stent Systems
Current Pharmaceutical Design Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials Hypertension in Hemodialysis Patients
Current Hypertension Reviews The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
Current Drug Discovery Technologies Anti-Thrombotic Properties of Tomato
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) microRNA Regulation as a Therapeutic Strategy for Cardiovascular Disease
Current Drug Targets Fabry Disease and Cardiovascular Involvement
Current Pharmaceutical Design Proresolution Mediators and Receptors: Novel Drug Targets for Enhancing Pharmacological Armamentarium against Periodontal Inflammation
Infectious Disorders - Drug Targets Fullerenes for Applications in Biology and Medicine
Current Medicinal Chemistry